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Background. A study was designed to see the role of ﬁne needle aspiration cytology (FNAC) in palpable breast lumps. Materials
and Methods. Four hundred and twenty ﬁve (425) patients came to the Department of Pathology King Edward Medical University,
Lahore in four years for FNAC of their palpable breast masses from June 2006 to June 2010. FNAC diagnosis was compared with
histological diagnosis to see the accuracy of ﬁne needle aspiration cytology for neoplastic lesions. Results. There were 271/425
benign, 120/425 malignant, and 32/425 suspicious smears. Inadequate samples were repeated twice or thrice, and the degree of
success was improved with consecutive repeating approaches. The frequency of inadequacy declined from 86 to 18, and 2 for ﬁrst,
second and third attempts, respectively. The number of repeats increased the diagnostic accuracy of aspirates which is statistically
signiﬁcant(P = .000).Invasiveductalcarcinomawasthemostcommonlyreportedlesionwithmaximumincidenceinthe4th,5th,
and 6th decades followed by invasive lobular carcinoma and other malignant lesions. The sensitivity, speciﬁcity, accuracy, negative
predictive value, and the positive predictive value of FNAC was 98%, 100%, 98%, 100%, and 97%, respectively. Conclusion.F N A C
servesasarapid,economical,andreliabletoolforthediagnosisofpalpablebreastlesionsbecausethecytopathologicalexamination
of these lesions before operation or treatment serves as an important diagnostic modality.
1.Introduction
Allbreastlesionsarenotmalignant,andallthebenignlesions
do not progress to cancer; however the accuracy of diagnosis
can be increased by a combination of preoperative tests (like
physicalexamination,mammography,ﬁne-needleaspiration
cytology, and core needle biopsy). These modalities are more
accurate, reliable, and acceptable when compared with a
single adopted diagnostic procedure despite of having their
own technical limitations [1, 2].
“As ﬁne-needle aspiration (FNA) has become a critical
component in the investigation of palpable breast masses;
false-negative diagnoses have become a major concern,
prompting re-evaluation of the deﬁnition of specimen ad-
equacy. Although cytopathologists agree that a number of
parameters relate to the adequacy of an FNA specimen, there
is no concsensus on the role of epithelial cell quantitation in
the determination of an adequate FNA. To better understand
the signiﬁcance of epithelial cellularity, false-negative FNA
samples from palpable breast lesions were reviewed” [3].
“Fine-needle aspiration (FNA) biopsy is an established
and highly accurate method for diagnosing breast lesions.”
The use of core biopsy (CB) is being increasingly advertised
but its procedure is more cumbersome, expensive and time
consuming as compared to FNA procedure [4–6]. Core Bi-
opsy or tru cut needle biopsy is not widely used because of
its complications, interpretation, and time-consuming re-
sults; therefore palpable breast lesions can be accurately
diagnosed by triple test only (FNAC, physical examination
and Mammography) [7].
“Although ﬁne-needle aspiration (FNA) biopsy of the
breast has been shown to be a safe and accurate technique,
many surgeons question whether it is reliable enough to
replace excisional biopsy. If FNA biopsy is followed by an
excisional biopsy for conﬁrmation, it would seem that the
costofdiagnosticworkupwouldbeincreased,butithasbeen2 Pathology Research International
seen that FNA biopsy is cost eﬀective even when followed
by an excisional or frozen section biopsy for conﬁrmation. It
is considered safe and reasonable to expand its use to smaller
hospitals where the personnel may be initially less experi-
enced with the technique” [8, 9].
It is considered a successful and less complicated pro-
cedure with excellent results; however the main factors in-
ﬂuencing success should be considered before its procedure
to increase its accuracy and these are “the aspirator, the small
sizeofmanycancers,andtheoccultnatureofthelesionsseen
only on mammography” [10].
Fine-needleaspirationcytology(FNAC)iswidelyusedin
Pakistan as a reliable, rapid, cost-eﬀective, complication free,
and an accurate diagnostic modality for the evaluation or
management of breast lumps. A study was conducted to see
theusefulnessofﬁne-needleaspiration(FNA)inscreeningof
palpable breast masses at the Department of Pathology, King
Edward medical University, Lahore, Pakistan.
2.MaterialandMethods
King Edward Medical University is the largest Medical Insti-
tute of Asia and Pakistan, comprising of four tertiary care
hospitals with record numbers of yearly registered patients
coming from all parts of the country. We have two programs
at our institution: one is screening of all palpable lumps for
early detection of malignancy and onsite diagnostic program
for all referral cases waiting for surgery and treatment.
A total of 425 patients came to the Department of Pa-
thology in four years for FNAC of their palpable breast
masses from June 2006 to June 2010.
Out of these 425 patients, 338 biopsies were collected for
comparison as inﬂammatory, and inadequate lesions were
excluded.
2.1. Patients Protocol. A designed proforma was used to col-
lect the consent and data of patients. History of lactation and
pregnancy was included in the proforma. All the lesions were
followed for biopsy except inﬂammatory and inadequate
samples. The inadequate lesions were advised a repeat
FNAC.Bothbenignandmalignanttumorswerefollowedup.
Patients were divided into groups, and their mean age was
calculated.
2.2. Procedure for Fine-Needle Aspiration Cytology (FNAC).
A written consent was taken before performing the FNAC.
FNA was done using a 23 gauge needle and 10mL disposable
syringe of Becton and Dickinson Pakistan (Pvt) for each
prick and for each patient. No local anesthetic was used, and
the needle was inserted into the palpable lesions, either once
or twice depending upon the size of the nodule. FNA gave
us cytological diagnoses, and we visualized at individual cells
but cellular structures and not at macrotissue architecture
like a histological specimen would. Cellular material was
aspirated into a syringe and expelled onto slides. Four to ﬁve
slides were prepared for each patient. A small or medium-
sized drop of aspirate was put near the frosted end of a slide
that was placed on a table. A second slide was used to spread
the aspirated material in the same manner used to prepare a
peripheral blood smear. All the smears were wet ﬁxed in 95%
methanol, and the air dried smears were stained with two
stainsHematoxylin&Eosin(H&E),andPapanicolaoustains.
The procedure was done within one hour, and the reports
were signed out within 2-3 hours.
2.2.1. Four Groups Were Deﬁned for the FNAC Diagnosis
(1) Inadequate
(2) Non neoplastic lesions
(3) Suspicious of malignancy
(4) Positive for malignancy.
NB: in the calculations, groups 3-4 were malignant.
2.3. Preparation of Cell Blocks. Remaining aspirates were
used for cell blocks, by putting 10% formalin in the syringes
used for FNA.
2.4. Procedure for Histopathology. Inﬂammatory (85) and
Inadequate (2) smears were not followed for their biopsies.
Remaining 338 (benign smears, suspicious, and malignant)
smears were followed for biopsies (76 mastectomies and 262
lumpectomies). These biopsy specimens were ﬁxed in 10%
formalin for 24 hours and then grossed in the Department
of Pathology by consultant histopathologists. The gross and
cut section ﬁndings were noted. Several bits were taken from
appropriate sites for processing and paraﬃn embedding.
From each block, sections were cut at 4-5 microns thickness
and stained by H&E.
2.5. Criteria for Selection of Patients. Inclusion criteria.
(1) All females with unknown primary diagnosis of
breast mass.
(2) Patientsconsentedforinclusioninstudyaccordingto
designed proforma.
Exclusion criteria.
(1) Patients with recurrent malignancy.
(2) Patients who underwent FNAC but did not undergo
subsequent histopathological diagnosis.
(3) Patients in whom FNAC was either acellular or non-
diagnostic or inﬂammatory.
(4) Past or current chemo-therapeutic or prevention
treatment.
(5) Male patients with breast cancer and gynecomastia.
2.6.StatisticalAnalysis. Datawascomputerizedwithwindow
SPSS version16. Speciﬁcity, sensitivity, accuracy, and predic-
tive values were calculated, P values were also calculated,
while correlation was seen by Pearson’s correlation curve.
3. Results
A total 425 ﬁne-needle aspirates (FNAs) were carried out
over a period of four years in the Department of Pathology.Pathology Research International 3
Table 1: Age of the patients presenting with lump breast.
Age in years
(n = 425) Inadequate Inadequate on
ﬁrst repeat
Inadequate
second repeat
Benign lesions
Suspicious for
malignancy Malignant
Inﬂammatory
Benign
proliferative
lesions
A
16–20 (n = 23) 4 1 0 4 (4.7%) 10 (5.8%) 6 (16.6%) 3 (2.3%)
B
21–30 (n = 76) 12 2 0 10 (11.8%) 50 (29.2%) 3 (8.3%) 13 (10%)
C
31–40 (n = 166) 27 5 1 52 (61%) 79 (46%) 7 (20%) 27 (20.6%)
D
41–50 (86) 23 4 0 14 (16.5%) 30 (17.5%) 11 (30.5%) 31 (23.6%)
E
51–60 (n = 53) 17 5 1 5 (5.8%) 2 (1.2%) 7 (20%) 38 (29%)
F
61–70 (n = 16) 2 1 0 0 0 1 (2.8%) 15 (11.5%)
G
<70 years (n = 5) 10000 1 ( 2 . 8 % ) 4 ( 3 % )
Total 86 18 2 85 (20%) 171 (40%) 36 (8.4%) 131 (31%)
Note: the number of repeat increased the diagnosis of aspirates which is statistically signiﬁcant (P = .000).
Table 2: Comparison of distribution of inﬂammatory lesions.
Inﬂammatory Lesions (n = 85) Cytology Histopathology
Acute suppurative Mastitis 20 (23.5%) Excluded
Acute mastitis 26 (30.5%) Excluded
Non-tuberculosis granulomatous mastitis 15 (17.6%) Excluded
Chronic nonspeciﬁc mastitis 12 (14%) Excluded
Duct ectasia 8 (9%) Excluded
Tuberculosis 2 (2.3%) Excluded
Fat necrosis 2 (2.3%) Excluded
Table 3: Comparison of distribution of inﬂammatory lesions.
Benign Lesions on cytology (n = 171) Cytology Histopathology
FA FSD FAN FEH AEH BPh Malignant
Fibroadenomas 70 (41%) 60 6 3 0 0 1 0
Fibrocystic disease 90 (52.6%) 10 70 5 3 1 1 0
Benign proliferative diseases 6 (9%) 0 0 2 3 0 1 0
Benign phyllodes 5 (3%) 2 0 0 0 0 3 0
Total 171 72 76 10 6 1 6 0
FA: ﬁbroadenoma, FCD: ﬁbrocystic disease, FAN: ﬁbroadenosis, AEH: atypical epithelial hyperplasia, FEH: ﬂorid epithelial Hyperplasia, and BPh: Benign
Phyllodes.
Table 4: Histopathological diagnosis of suspicious and malignancy smears.
Cytology
Histopathology
Malignant results Benign results
DCIS IDC LCIS ILC MC MDC MTC Lymph MPhy FA FAN SCA
Suspicious for malignancy (n = 36;8.4%) 15 10 4 4 0 0 0 0 0 1 2 1
Malignant lesions (n = 131;30.8%) 4 100 2 16 2 1 1 1 4 0 0 0
FA: ﬁbroadenoma, FAN: ﬁbroadenosis, SCA: sclerosing adenosis, DCIS: ductal carcinoma Insitu. IDC: invasive ductal carcinoma, LCIS: lobular carcinoma
In situ, ILC: invasive lobular carcinoma, MC: mucinous carcinoma, MDC: medullar carcinoma, MTC: metaplastic carcinoma, Lymph: lymphoma: MPh:
malignant phyllodes.4 Pathology Research International
Table 5: The Diagnostic accuracy of FNAC in histologically correlated cases.
FNAC result Histopathological diagnosis Total
Positive for malignancy 163 (TP) 4 (FP) 167
Negative for malignancy 0 (FN) 171 (TN) 171
Total 163 175 338
Sensitivity: 100%, Speciﬁcity = 98%, Accuracy = 98%, PPV = 97%, NPV = 100%.
(a) (b)
Figure 1: (a) Photomicrograph on FNAC of a benign smear (H&E stain 10x) of Fibroadenoma showing sheet of regularly arrange epithelial
cells (Stag horn pattern) and numerous bare nuclei. (b) Comparison on Histopathology (10x H&E) of ﬁbroadenoma breast.
There were 85 inﬂammatory lesions and 2 smears inconclu-
sive. Remaining 338 (benign smears, suspicious, and malig-
nant) smears were followed for biopsies (76 mastectomies
and 262 lumpectomies). There were total of 256/425 (60%)
benign lesions comprising of 85 (20%) inﬂammatory aspi-
rates and 171(40%) benign proliferative lesions. Cytological
diagnoses of other aspirations were reviewed, and lesions
were classiﬁed into four diagnostic classes revealing 171
benign proliferative lesions, 131 malignant, 36 suspicious,
and 2 inadequate smears (Table 4).
3.1.FollowupofInadequateSmears. Inadequatesampleswere
repeated twice and degree of success was improved with
two consecutive approaches with an interval of 24 hours
in subsequent repeats. There were 86, 18, and 2 inadequate
smears in ﬁrst, second, and third approach. The number of
repeatsincreasedthediagnosticaccuracywhichisstatistically
signiﬁcant (P = .000). There were maximum lesions during
the reproductive age groups, and most of these were benign.
Maximum malignant lesions were seen in older age groups.
This relationship was statistically signiﬁcant when compared
by Pearson correlation curve. A positive correlation was
observed between benign and malignant lesions (r = 0.95,
P<. 0001) (Table 1, Figure 9). The age of the patients ranged
between 16 to >70 years. The youngest patient diagnosed
as invasive ductal carcinoma (IDC) was seen at 16 years
of age. In our study, most of the benign lesions were re-
ported (29.2% & 46%) in 3rd and 4th decades of life, while
maximum numbers of malignant lesions (23.6 and 29%)
were reported in 5th and 6th decades (Table 1).
There were 23.6%, 30.6%, 17.6%, 14%, 9%, 2.3%, and
2.3% lesions of acute suppurative mastitis, acute mastitis,
non-tuberculous mastitis, chronic nonspeciﬁc mastitis, duct
ectasia, tuberculous mastitis, and fat necrosis, respectively.
The diagnosis of these lesions was made by cytology and
histology of cell blocks (Table 2).
In benign proliferative breast lesions, we were very
conscious about over-diagnosis, therefore our reporting style
wasas“smearnegativeformalignantlesions”,andforfurther
analysis we advised an excision biopsy. For deﬁnite diagnosis
ourreportswerelimitedtoFibroadenoma,ﬁbrocysticchange
disease, benign proliferative disease, and Phyllodes tumors.
For uncertain categories we only reported “benign prolifer-
ative lesions”. This class of diseases constituted the largest
groupoflesionswithmaximumincidenceinthe3rd,4thand
5th decades of life (Tables 1 and 3).
Invasive ductal carcinoma was the most common malig-
nant lesion reported in our study with a maximum incidence
in the 4th, 5th, and 6th decades, followed by invasive lobular
carcinoma and other malignant lesions (Table 5). Following
histopathologic correlation with FNA, we calculated the sen-
sitivity, speciﬁcity, and positive predictive values.
There were 4 false positive cases and no false negative
cases in this study. False positives were observed in the sus-
picious lesions.
False positives noted mainly in the interpretation of
suspicious smears or with atypical features, were due to uni-
formly enlarged nuclei with prominent nucleoli, occasional
marked nuclear enlargement, and moderate pleomorphism
seen in ﬁbrocystic disease or ﬁbroadenoma. RegardingPathology Research International 5
(a) (b)
Figure 2:(a)PhotomicrographonFNACofabenignsmearofBenignPhyllodes(H&Estain20x)showingcellularsmearofspindledstromal
cells. (b) Comparison on Histopathology of Benign Phyllodes.
(a) (b)
Figure 3: (a) Photomicrograph on FNAC of a suspicious smear (H&E stain 40x) of breast showing increased cellularity with mild
pleomorphism and discohesion but lacking other features of malignancy. (b) Comparison on histopathology of atypical ductal hyperplasia.
benign proliferative and malignant lesions no false positivity
was seen. Therefore, in the this study, the sensitivity was
100%, speciﬁcity 98%, accuracy 98%, negative predictive
value 100%, and the positive predictive value was 97%
(Table 5).
All the FNAC smears are compared with histopathology
and the details given in Figures 1, 2, 3, 4, 5, 6, 7,a n d8.
4. Discussion
Fine-needle aspiration cytology is widely used in the diagno-
sis of breast cancer because it is an excellent, safe, and cost-
eﬀectivediagnosticprocedure.Onecangetonsiteimmediate
report with minimal cost using inexpensive equipments and
a simple technique. The most signiﬁcant advantage of FNAC
is the high degree of accuracy, rapid results, and a less in-
vasive procedure than a tissue biopsy. FNAC of the breast can
reduce the number of open breast biopsies [11–14].
Thefrequencyofinadequatecasesarevariableisdiﬀerent
studies ranging from 0 to 57.2% depending on various
factors. The main causes for inadequate smears may be
due to either lack of technical experience in performing
FNA, preparation, and ﬁxation of smears. FNA of ill-deﬁned
masses like or lesions with hyalinization and deeply located
lumps may also be contributed to the inconclusive diagnosis
[15, 16].
Many inﬂammatory breast lesions create confusion as
these are presented as a palpable mass. “Mammographic,
sonographic, and magnetic resonance imaging ﬁndings may
not always distinguish some of the benign lesions like duct
ectasia, fat necrosis from a malignant lesion.” Fine-needle
aspiration (FNA) is a well-accepted diagnostic modality and6 Pathology Research International
(a) (b)
Figure 4: (a) Photomicrograph on FNAC of a malignant smear of ductal carcinoma (40x Pap stain) showing variation in nuclear shape and
size, with decreased intercellular cohesion and dirty background (b) Comparison on histopathology of invasive ductal carcinoma
(a) (b)
Figure 5: (a) Photomicrograph on FNAC of a malignant smear’s depicting cytological features of lobular carcinoma (20x H&E stain).
Groups of small, round, uniform cells with distinct cell membrane and discohesion. (b) Comparison on histopathology showing uniform
cells arranged in alveolar pattern of lobular carcinoma.
procedure for the diagnosis of inﬂammatory swellings of
breasts. We are using this technique in such lesions, and
resultsarevariablyacceptedbyourconsultantsandclinicians
with varying degrees of acceptance rates, accuracy, and re-
sults. Fine-needle aspiration is the most accurate diagnostic
modality for these lesions and cell blocks accentuate the
reliability of the diagnosis in these benign inﬂammatory and
curable lesions without requirement of excision biopsy or
other second-line investigations. In this study, these were
reported as benign inﬂammatory diseases and their histo-
pathologies was followed and were further categorized into
diﬀerent lesions. Cell blocks were prepared after making the
required smears and were processed for histopathology [17–
19].
There were 85 (20%) cases of benign inﬂammatory
lesions, and the majority of these were of acute and chron-
ic mastitis. “Granulomatous mastitis is a rare chronic in-
ﬂammatory breast lesion that mimics carcinoma clinically
and radiologically” [19–21]. There were 2 (2.3%) cases of
tuberculosis; deﬁnitive diagnosis of the tuberculous mastitis
was based on identiﬁcation of typical histological features
under microscopy and detection of tubercle bacilli on Ziehl-
Neelsen stain. There were 8 (9%) patients of duct ectasia
whose histological diagnosis was based on observing dilata-
tion of major ducts which contained eosinophilic granular
secretions and foamy histiocytes both within the duct ep-
ithelium and in the lumen. Two cases of fat necrosis were
also reported on histopathology, characterized by “anu-
cleated fat cells surrounded by histiocytic giant cells and
foamy macrophages”. Our ﬁndings are consistent with Ne-
menqani et al. that primary tuberculous mastitis is very rare
in Pakistan [19].Pathology Research International 7
(a) (b)
Figure 6: (a) Photomicrograph on FNAC of a malignant smear of Non-Hodgkin Lymphoma (H&E stain 40x). Sheets of noncohesive cells
with scanty cytoplasm. (b) Comparison on histopathology of non Hodgkin’s lymphoma (40x H&E).
(a) (b)
Figure 7: (a) Photomicrograph on FNAC of a malignant smear’s of colloid carcinoma (20x Giemsa stain) with loose clusters of epithelial
cells against abundant mucin. (b) Comparison on histopathology of mucinous carcinoma breast (10x H&E).
FNAC has some pitfalls in the diagnosis of Fibrocys-
tic disease (FCD), adenosis, epithelial hyperplasia with or
without atypia, apocrine metaplasia, radial scar, and papil-
loma“[22].Fibroadenomaandthesebenignlesionsaremore
common in our setup. Various types of adenosis have also
been described, of which sclerosing adenosis and microglan-
dular adenosis merit detailed description and most of these
lesions mimic malignant lesions” [23].
In this study, 338 FNA aspirations were correlated with
histopathology to evaluate the diagnostic sensitivity, speci-
ﬁcity, and accuracy of this diagnostic modality. Among these
lesions 171 (40%) were benign proliferative lesions. In
our center, we further categorized these lesions into three
main groups; namely ﬁbroadenoma, ﬁbrocystic disease, and
benign proliferative diseases. The spindle cell lesions were
diagnosed as benign Phyllodes on cytology reports. These
resultswereconﬁrmedbyhistopathologyfromthecellblocks
and tru-cut biopsies. In our study, no malignancy was seen
while few discrepancies were seen in making ﬁnal categories
like out of 70 FNAC diagnosed FA, there were 60, 6,3, and
1 FA, FCD (When there were mixture of cysts, ﬁbrosis, and
proliferating ductal epithelium), FAN (overgrowth of both
ﬁbrous stroma, and of epithelial elements, i.e., ducts and
lobules, in diﬀering proportions), and benign Phyllodes
on histopathology. From 90 FCD, there were 70 FCD on
histopathology while other were 10, 5, 3, 1, and 1 cases of FA,
FAN, ﬂorid epithelial hyperplasia (FEH), atypical epithelial
hyperplasia (AEH), and benign Phyllodes, respectively.
Inourexperience,FNACresultsaremorereliableregard-
ing malignant lesions; however the category of “Suspicious
for Malignant Lesions” needs histopathological evaluation
before performing surgical measures. Self-assessment, mam-
mography, and tru-cut biopsy may help in the accuracy of
these lesions [2].8 Pathology Research International
(a) (b)
Figure 8: (a) Photomicrograph on FNAC of a malignant smear of medullary carcinoma (H&E stain at 40x) showing large to medium sized
cells with large nucleoli with syncytial pattern against lymphoplasmacytic cells. (b) Comparison on Histopathology of Medullar carcinoma
Breast (40x H&E).
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Figure 9: Correlation between Benign and malignant lesions in
diﬀerent Age groups of patients presented with lump breast. Note:
A positive correlation was observed between Benign and malignant
lesions (r = 0.95, P<. 0001).
It is widely accepted that FNA is a less traumatic and
easy technique than core needle biopsy because we repeated
the FNAC in case of inadequate smears without any delay,
diﬃculty, trauma, and getting highly accurate results. This
statement is not applicable for open biopsy as it is a time
consuming and cumbersome technique which requires ﬁx-
ation, processings, staining and so forth. It is also expensive
procedure costing Rs 700 (9.5 USD) as compared to Rs 200
(2.5USD)foreachFNAwhileitisalsoexpensiveinadvanced
countries. In a study Rubin et al. has mentioned a saving of
1000$ with this cost eﬀective procedures [4]. In our study
the accuracy of FNA aspiration was increased by repeating
the process within 24 hours and was found to be signiﬁcant
(P = .000). There were many reasons for inadequate smears
like size, type of lesions, experience of the technical staﬀ,a n d
cooperation of patients in our study.
We have a proper and permanent FNAC modality room,
onsite service, technical trained staﬀ, expert consultants,
and a large number of postgraduate students available for
F N As e r v i c e .W ep r o v i d e9 0 %f r e es e r v i c e s ;h o w e v e r ,o u r
charges are 1.2 USD for the aﬀording cases. We have direct
interaction with the clinicians, patients, and our laboratory
technical staﬀ. In our study, no false negative cases were
reported when compared with histopathology.
Only four cases were observed as being false positives
(1.7%). False positives were interpreted as “suspicious for
malignancy” that were later on reported as benign prolifer-
ative lesions on histopathology. All benign and malignant
reported aspirates showed 100% accuracy. In this study the
sensitivity was 100%, and the speciﬁcity was only 98%
because of false positives when compared with the histologi-
cal reports.
There is a wide range of false results regarding the
credibilityofFNAC.Therateoffalsenegatives,falsepositives
varied from 0% to 10% in various studies [4, 24, 25]. Our
results are consistent with our previous study and other
studies in Pakistan and other areas. “The overall results in
our previous study for sensitivity, speciﬁcity, accuracy,
PPV, and NPV were 97%, 100%, 97%, 100%, and 87%,
respectively” [2]. The reasons for such a large range of var-
iable results are multifactorial and the main factors being
the small number of cases of FNA published, lack of onsite
service,andcoordinationbetweensurgeons,radiologistsand
pathologists [24, 26].
5. Conclusion
The cytological examination of breast lesions prior to sur-
gical treatment serves as a rapid, economical, and valuable
diagnostictool.Adheringtotheprincipleof“Tripletest,”andPathology Research International 9
acquisition of technical, observational, and interpretative
skills will further enhance the diagnostic accuracy of prolif-
erative conditions with atypia or suspicious lesions of breast.
6. Recommendations
(1) Proper training and skilled courses should be ar-
ranged for the technical staﬀ because it increases the
reliability and accuracy of the test.
(2) No overemphasis should be made in the reporting
of FNA, and very careful strict criteria should be
adaptedlikeadvisedrepeatFNAC,cellblockprepara-
tion, biopsy or correlation with clinical ﬁndings and
so forth. Three tier system should be used instead of
5 classes of the breast cytology, for example, benign,
suspicious, and malignant. FNAC should be repeated
when inadequate and improper smears are prepared.
(3) When the results are obviously benign, patients
should be reassured and can be prevented from un-
dergoing unnecessary surgery while in the case of
a clearly malignant smears, surgery and other treat-
ment should be started without any delay.
(4) For the gray areas, for example, suspicious and
inadequate smears, either repetition of the FNA or a
surgical biopsy should be recommended.
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